News

Deal Announcements

Alvine Pharma Lands $6 Million Venture Capital Debt

Friday, January 4, 2013 5:35:00 AM PDT | VentureDeal
San Carlos, California  --  Alvine Pharmaceuticals has secured $6 million in new venture capital investment, according to an SEC filing.

Alvine is developing and commercializing therapeutics for the treatment of Celiac sprue.

Investors in the round were not disclosed, nor was how the company intends to use the proceeds.

Alvine is still seeking $500,000 in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1